Together, these results provide convincing evidence that SNPs in the nicotinic acetylcholine receptor locus on chromosome 15 modulate expression levels of IREB2 and, thus, implicate IREB2 expression levels in the individual risk for lung cancer. The gene discussed is IREB2; the disease is lung cancer.